Drug discovery and development is a lengthy process, often starting with the identification of new drug targets – based on NGS data – which are then validated using standard in vitro models before moving to in vivo testing and ultimately to clinical trials. This is a lengthy and risky process and oftentimes drugs with promising preclinical pharmacological profiles fail to translate their efficacy in patients.


Have any questions?

contact us